CXCL10 and systemic lupus erythematosus: Meanwhile, CXCL10 was associated with UC progression[1], and it was up-regulated in cytokine activity, complement and coagulation cascades, cytokine-cytokine receptor interaction, and systemic lupus erythematosus, which shed light on the drug target for UC patients.